Literature DB >> 12195242

Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.

Vladimir Khavinson1, Michael Razumovsky, Svetlana Trofimova, Roman Grigorian, Anna Razumovskaya.   

Abstract

We have studied the effect of tetrapeptide Epitalon (Ala-Glu-Asp-Gly) on the course of congenital pigmented degeneration of the retina. The application of Epitalon in Campbell rats is found to intensify the bioelectric and functional activity of the retina due to the preservation of its morphological structure. Epitalon therapy in patients with degenerative retinal lesions results in a positive clinical effect in 90% of the cases. The analysis of Epitalon effects suggests that the tetrapeptide participates in the mechanisms of transcription common for the epiphysis and retina.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195242

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

1.  Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors.

Authors:  V Khavinson; S Trofimova; A Trofimov; I Solomin
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 2.  Peptide Regulation of Cell Differentiation.

Authors:  Vladimir Khavinson; Natalia Linkova; Anastasiia Diatlova; Svetlana Trofimova
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

Review 3.  Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa.

Authors:  Marta Sacchetti; Flavio Mantelli; Daniela Merlo; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2015-08-03       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.